D.E. Shaw & Co’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
APM
LPC
D.E. Shaw & Co's BLUE Position: Q3 2024 in Review
D.E. Shaw & Co sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 5,859 shares — an estimated $115K sold.
D.E. Shaw & Co first reported a position in BLUE in Q4 2014 and held it in 29 quarters. The position peaked at $20M in Q4 2017. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.
- D.E. Shaw & Co reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
- D.E. Shaw & Co sold 5,859 bluebird bio shares in Q3 2024, an estimated $115K.
- D.E. Shaw & Co first reported a position in bluebird bio in Q4 2014 and held it in 29 quarters.
- D.E. Shaw & Co's bluebird bio position peaked at $20M in Q4 2017.
- 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.